Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transportin-2 (TNPO2) is a highly conserved nuclear transport receptor of the karyopherin/importin-β superfamily that mediates the import and shuttling of proteins between the cytoplasm and nucleus through the nuclear pore complex[1][2][3][4]. TNPO2 recognizes and binds proteins with specific nuclear localization signals, especially PY-NLS motifs and arginine-glycine-glycine (RGG) domains, and facilitates their RanGTP-dependent passage into the nucleus[1][2]. It shares high sequence and functional similarity with Transportin-1 (TNPO1) but has specificity for different cargos, including proteins involved in DNA repair and high mobility group (HMG) proteins[1]. TNPO2 also acts as a cytoplasmic retention factor for certain cargoes, such as estrogen receptor α (ERα), competing with other importins to regulate nuclear-cytoplasmic distribution and subsequent signaling activity[3]. Impairment of TNPO2 function is associated with protein aggregation, particularly in neurons, and has been linked to neurodegenerative disease and developmental disorders[1][2]. No clinically established drugs are known to robustly target TNPO2, and it is not currently a common therapeutic target, but its essential role in nucleocytoplasmic transport implicates it in a broad range of cellular and disease processes[1][2][3].
RanGTP-dependent nucleocytoplasmic transport, Competitive inhibition of importin α/β1 pathway, Cytoplasmic retention of cargo proteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transportin-2 (TNPO2).